Physician Dominique Stoppa-Lyonnet is a professor of genetics at Paris Descartes University and heads up the Department of Genetics at Institut Curie. She sits on the Oncogenetics Board of the French National Cancer Institute (INCa). She was a member of the Scientific and Medical Board of the French Biomedicine Agency (ABM) from 2005 to 2015 and the French National Consultative Ethics Committee (CCNE) from 2005 to 2013.
Prof. Stoppa-Lyonnet specializes in the diagnosis of predisposition to cancer, particularly breast and ovarian cancer. She works in clinical genetics and in the laboratory, where her research focuses on rare DNA repair disorders and the genetic epidemiology of predisposition to breast and ovarian cancer, as well as the treatment of women at high risk of these cancers. She played a key role in opposing the patents of the BRCA1 and BRCA2 genes awarded by the European Patent Office.
She was co-rapporteur of two CCNE opinions on the ethical issues relating to pre-natal and pre-implantation genetic diagnosis, and non-invasive prenatal testing. Finally, she coordinated a report on the role of pre-natal and pre-implantation testing for hereditary forms of cancer, at the request of the ABM and INCa.
In March 2014, she became a Paris city councilor for the fifth arrondissement, and has been a metropolitan councilor since January 2016.